1. Home
  2. EIC vs XOMA Comparison

EIC vs XOMA Comparison

Compare EIC & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EIC

Eagle Point Income Company Inc.

HOLD

Current Price

$11.19

Market Cap

293.8M

Sector

Finance

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$29.71

Market Cap

322.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIC
XOMA
Founded
N/A
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.8M
322.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
EIC
XOMA
Price
$11.19
$29.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$14.00
$63.25
AVG Volume (30 Days)
266.9K
371.9K
Earning Date
02-19-2026
11-12-2025
Dividend Yield
11.91%
N/A
EPS Growth
N/A
N/A
EPS
1.14
0.82
Revenue
$59,262,402.00
$47,106,000.00
Revenue This Year
$37.84
$77.29
Revenue Next Year
$23.33
$34.91
P/E Ratio
$9.75
$36.42
Revenue Growth
44.30
118.02
52 Week Low
$10.81
$18.35
52 Week High
$16.39
$39.92

Technical Indicators

Market Signals
Indicator
EIC
XOMA
Relative Strength Index (RSI) 44.72 57.12
Support Level $10.93 $25.30
Resistance Level $11.60 $28.61
Average True Range (ATR) 0.23 1.58
MACD 0.00 0.66
Stochastic Oscillator 40.26 83.53

Price Performance

Historical Comparison
EIC
XOMA

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: